#TEPP-46

[neurosciencenews]

Promising Multiple Sclerosis Drug Could Worsen Disease 

TEPP-46, a drug developed for the treatment of cancer and which showed promise for the treatment of multiple sclerosis, could make MS symptoms worse, a new study reports. The drug appears to redirect inflammation away from the spinal cord and directly into the brain.